German Center for Infection Research:
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious...
Summary: A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on...
Hi everyone, I'm new to the forum, in June 2022 I got what I presume was a viral illness, with symptoms such as fever, cough, throat pain and slight dysphagia.
All symptoms besides the dysphagia subsided until I got tired moving for a new job and, between July and August, I first developed...
Study finds CAR T-cell treatment sends lupus into remission, raising hopes it could be used to treat diseases such multiple sclerosis
Five people with severe autoimmune disease have become the first in the world to receive a groundbreaking therapy that uses genetically altered cells to drive...
In a small trial, immune cells that fight the Epstein-Barr virus have stopped the progression of multiple sclerosis, an autoimmune condition that can lead to symptoms, such as difficulty walking, that worsen over time...
Has anybody access to the full article?
I would appreciate it. Thank you.
Understanding factors that lead to the development of multiple sclerosis might aid efforts to develop new therapies. Clinical data now implicate a viral culprit and immune-system dysfunction as underlying factors in...
https://www.scientificamerican.com/article/epstein-barr-virus-found-to-trigger-multiple-sclerosis/
I think this is a very interesting finding, EBV is clearly not mostly benign anymore and ME/CFS has some interesting similarities to MS and doctors often struggle to rule it out early on in...
Authors: Achilles Ntranos, Hye-Jin Park, Maureen Wentling, Vladimir Tolstikov, Mario Amatruda, Benjamin Inbar, Seunghee Kim-Schulze, Carol Frazier, Judy Button, Michael A Kiebish,
Fred Lublin, Keith Edwards, Patrizia Casaccia
Published on: December 11, 2021
doi: 10.1093/brain/awab320
Abstract
I was doing a bit of research for a friend with MS and came across this list of experimental treatments for MS. Drugs in various phases of research. I thought it was a really easy to digest list with just the right amount of info on each and it got me wondering if any of these might be relevant...
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk
Katarina Tengvall, Jesse Huang, Cecilia Hellström, Patrick Kammer, Martin Biström, Burcu Ayoglu, Izaura Lima Bomfim, Pernilla Stridh, Julia Butt, Nicole Brenner, Angelika...
I notice a lot of similarities between MS and ME/CFS. Is it possible some ME/CFS folks might actually have MS? What are the more significant differences in symptoms? Is there a definitive test for MS? Any thoughts ....
Fatigue heralding multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pubmed/23439577
Mult Scler. 2013 Feb 25. [Epub ahead of print]
Fatigue heralding multiple sclerosis.
Berger JR, Pocoski J, Preblick R, Boklage S.
Source
Department of Neurology, University of Kentucky College of Medicine...
http://www.bbc.co.uk/news/health-20836082
A simple eye test may offer a fast and easy way to monitor patients with multiple sclerosis (MS), medical experts say in the journal Neurology.
Optical Coherence Tomography (OCT) is a scan that measures the thickness of the lining at the back of the...